APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 217 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $284,961 | +27.9% | 3,128 | -7.4% | 0.16% | +19.6% |
| Q1 2023 | $222,813 | -24.7% | 3,378 | -41.0% | 0.14% | -31.7% |
| Q4 2022 | $296,040 | -89.5% | 5,725 | -86.2% | 0.20% | -89.6% |
| Q3 2022 | $2,825,000 | +769.2% | 41,365 | +476.2% | 1.94% | +742.0% |
| Q2 2022 | $325,000 | -7.1% | 7,179 | +4.4% | 0.23% | +4.1% |
| Q1 2022 | $350,000 | -38.6% | 6,879 | -43.0% | 0.22% | -36.6% |
| Q4 2021 | $570,000 | +172.7% | 12,060 | +264.4% | 0.35% | +171.3% |
| Q2 2021 | $209,000 | -11.8% | 3,310 | -40.1% | 0.13% | -15.7% |
| Q1 2021 | $237,000 | -27.5% | 5,523 | -3.4% | 0.15% | -31.7% |
| Q4 2020 | $327,000 | – | 5,718 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |